Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor

Author: Dragun D.   Brasen J.H.   Schonemann C.   Fritsche L.   Budde K.   Neumayer H.-H.   Luft F.C.   Wallukat G.  

Publisher: Elsevier

ISSN: 0041-1345

Source: Transplantation Proceedings, Vol.35, Iss.6, 2003-09, pp. : 2104-2105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content